We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

196 hedge funds and large institutions have $1.97B invested in Pacira BioSciences in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 54 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

56% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 54

25% more call options, than puts

Call options by funds: $23.1M | Put options by funds: $18.5M

14% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 29

2% more funds holding

Funds holding: 192 → 196 (+4)

5% more capital invested

Capital invested by funds: $1.87B → $1.97B (+$93M)

6.75% less ownership

Funds ownership: 109.53% → 102.79% (-6.7%)

Holders
196
Holders Change
+4
Holders Change %
+2.08%
% of All Funds
4.89%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.12%
New
33
Increased
84
Reduced
54
Closed
29
Calls
$23.1M
Puts
$18.5M
Net Calls
+$4.57M
Net Calls Change
-$2.33M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$32.2M
2
Millennium Management
Millennium Management
New York
+$27.5M
3
EVM
Eaton Vance Management
Massachusetts
+$19M
4
GPP
Great Point Partners
Connecticut
+$13.9M
5
CHP
Castle Hook Partners
New York
+$13.7M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$44.3M
2
PC
PointState Capital
New York
-$29.4M
3
CCM
Cadian Capital Management
New York
-$28M
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$23M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$21M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
76
California Public Employees Retirement System
California
$3.09M +$65K +1,400 +2%
Swiss National Bank
77
Swiss National Bank
Switzerland
$3.01M +$83.5K +1,800 +3%
OAM
78
Oxford Asset Management
United Kingdom
$2.92M +$2.07M +44,610 +267%
MOACM
79
Mutual of America Capital Management
New York
$2.89M -$83.6K -1,802 -3%
TCM
80
Tygh Capital Management
Oregon
$2.8M -$2.39M -51,410 -47%
CS
81
Candriam SCA
Luxembourg
$2.53M -$325K -7,000 -12%
Two Sigma Advisers
82
Two Sigma Advisers
New York
$2.49M +$1.75M +37,800 +263%
American Century Companies
83
American Century Companies
Missouri
$2.4M -$94.7K -2,041 -4%
RhumbLine Advisers
84
RhumbLine Advisers
Massachusetts
$2.35M +$77.6K +1,672 +4%
SAM
85
Sandell Asset Management
New York
$2.27M +$2.21M +47,600 New
LCP
86
Legacy Capital Partners
Wisconsin
$2.23M +$141K +3,045 +7%
SEI Investments
87
SEI Investments
Pennsylvania
$1.93M +$807K +17,388 +75%
MCM
88
Marsico Capital Management
Colorado
$1.84M – – –
Ohio Public Employees Retirement System (OPERS)
89
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.78M +$1.73M +37,366 New
AI
90
Axiom Investors
Connecticut
$1.74M +$278K +5,988 +20%
AA
91
ALPS Advisors
Colorado
$1.73M +$186K +4,008 +12%
PIM
92
Partner Investment Management
California
$1.72M +$88.4K +1,906 +6%
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$1.61M -$327K -7,053 -17%
RA
94
RiverPark Advisors
New York
$1.56M – – –
SCM
95
Suffolk Capital Management
New York
$1.54M +$114K +2,457 +8%
TD Asset Management
96
TD Asset Management
Ontario, Canada
$1.46M -$264K -5,700 -16%
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.45M +$86.9K +1,872 +7%
State of Wisconsin Investment Board
98
State of Wisconsin Investment Board
Wisconsin
$1.38M +$1.35M +29,000 New
MWNA
99
Marshall Wace North America
New York
$1.35M +$1.31M +28,214 New
N
100
Nuveen
North Carolina
$1.33M +$1.29M +27,819 New
2 3
4
5 6

PCRX Hedge Fund Activity: Q2 2017 in Review

196 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q2 2017, worth a combined $1.97B — up 5% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new PCRX positions and 29 closed out — a net gain of 4 holders — while 84 added to existing stakes and 54 trimmed.

The largest buyer was HealthCor Management, adding an estimated $32.2M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $44.3M sold.

  • 196 institutional investors held Pacira BioSciences (PCRX) as of Q2 2017, up from 192 in Q1 2017.
  • Funds reported $1.97B of Pacira BioSciences stock for Q2 2017, up 5% quarter-over-quarter.
  • 33 funds opened new Pacira BioSciences positions in Q2 2017 and 29 closed out, a net change of +4 holders.
  • The largest Pacira BioSciences buyer in Q2 2017 was HealthCor Management, an estimated $32.2M added.
  • The largest Pacira BioSciences seller in Q2 2017 was Consonance Capital Management, an estimated $44.3M sold.

Based on aggregated 13F filings for Q2 2017.